Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00399529 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: November 13, 2006 Last Updated: August 31, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2013
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)